Suppr超能文献

重组腺病毒载体可通过E4-orf6/7蛋白诱导p73的表达。

Recombinant adenoviral vectors can induce expression of p73 via the E4-orf6/7 protein.

作者信息

Shapiro Gary S, Van Peursem Crystal, Ornelles David A, Schaack Jerome, DeGregori James

机构信息

Department of Biochemistry and Molecular Genetics, Mail Stop 8101, Aurora, CO 80045, USA.

出版信息

J Virol. 2006 Jun;80(11):5349-60. doi: 10.1128/JVI.02016-05.

Abstract

Despite the utility of recombinant adenoviral vectors in basic research, their therapeutic promise remains unfulfilled. Most engineered adenoviral vectors use a heterologous promoter to transcribe a foreign gene. We show that adenoviruses containing the cytomegalovirus immediate-early promoter induce the expression of the proapoptotic cellular protein TAp73 via the cyclin-dependent kinase-retinoblastoma protein-E2F pathway in murine embryonic fibroblasts. Cells transduced with these vectors also expressed high levels of the adenoviral E4-orf6/7 and E2A proteins. By contrast, adenoviruses containing the ubiquitin C promoter failed to elicit these effects. E4-orf6/7 is necessary and sufficient for increased TAp73 expression, as shown by using retrovirus-mediated E4-orf6/7 expression and adenovirus with the E4-orf6/7 gene deleted. Activation of TAp73 likely occurs via E4-orf6/7-induced dimerization of E2F and subsequent binding to the inverted E2F-responsive elements within the TAp73 promoter. In addition, adenoviral vectors containing the cytomegalovirus immediate-early promoter, but not the ubiquitin C promoter, cooperated with chemotherapeutic agents to decrease cellularity in vitro. In contrast to murine embryonic fibroblasts, adenoviruses containing the ubiquitin C promoter, but not the cytomegalovirus immediate-early promoter, induced both E4-orf6/7 and TAp73 in human foreskin fibroblasts, emphasizing the importance of cellular context for promoter-dependent effects. Because TAp73 is important for the efficacy of chemotherapy, adenoviruses that increase TAp73 expression may enhance cancer therapies by promoting apoptosis. However, such adenoviruses may impair the long-term survival of transduced cells during gene replacement therapies. Our findings reveal previously unknown effects of foreign promoters in recombinant adenoviral vectors and suggest means to improve the utility of engineered adenoviruses by better controlling their impact on viral and cellular gene expression.

摘要

尽管重组腺病毒载体在基础研究中具有实用性,但其治疗前景仍未实现。大多数工程化腺病毒载体使用异源启动子来转录外源基因。我们发现,含有巨细胞病毒立即早期启动子的腺病毒通过细胞周期蛋白依赖性激酶 - 视网膜母细胞瘤蛋白 - E2F途径在小鼠胚胎成纤维细胞中诱导促凋亡细胞蛋白TAp73的表达。用这些载体转导的细胞也高水平表达腺病毒E4 - orf6/7和E2A蛋白。相比之下,含有泛素C启动子的腺病毒未能引发这些效应。如通过逆转录病毒介导的E4 - orf6/7表达和缺失E4 - orf6/7基因的腺病毒所示,E4 - orf6/7对于增加TAp73表达是必要且充分的。TAp73的激活可能是通过E4 - orf6/7诱导的E2F二聚化以及随后与TAp73启动子内的反向E2F反应元件结合而发生的。此外,含有巨细胞病毒立即早期启动子而非泛素C启动子的腺病毒载体与化疗药物协同作用以在体外降低细胞数量。与小鼠胚胎成纤维细胞相反,含有泛素C启动子而非巨细胞病毒立即早期启动子的腺病毒在人包皮成纤维细胞中诱导E4 - orf6/7和TAp73,强调了细胞背景对于启动子依赖性效应的重要性。因为TAp73对化疗疗效很重要,所以增加TAp73表达的腺病毒可能通过促进细胞凋亡来增强癌症治疗效果。然而,此类腺病毒可能在基因替代疗法期间损害转导细胞的长期存活。我们的研究结果揭示了重组腺病毒载体中外源启动子以前未知的效应,并提出了通过更好地控制其对病毒和细胞基因表达的影响来提高工程化腺病毒实用性的方法。

相似文献

本文引用的文献

7
E1A and E1B proteins inhibit inflammation induced by adenovirus.E1A和E1B蛋白可抑制腺病毒诱导的炎症反应。
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3124-9. doi: 10.1073/pnas.0303709101. Epub 2004 Feb 19.
8
China approves first gene therapy.中国批准首例基因疗法。
Nat Biotechnol. 2004 Jan;22(1):3-4. doi: 10.1038/nbt0104-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验